You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (5) |
Back to Search
Profile of adverse drug reactions related to the use of gatifloxacin identified by intensive surveillance in an universitary hospital
- In: SIG Pharmacoeconomics/Pharmacoepidemiology - Poster Session
- At: Salvadore (Brazil) (2006)
- Type: Poster
- Poster code: PP-P-002
- By: REIS, Adriano Max Moreira (Faculdade de Farmácia UFMG, Belo Horizonte, Brazil)
- Co-author(s): Padovani, Maria (Hospital das Clínicas UFMG, Belo Horizonte, Brazil)
Gomes, Dênia (Faculdade de Farmácia UFMG, Belo Horizonte, Brazil)
Campos, Marcela (Faculdade de Farmácia UFMG, Belo Horizonte, Brazil)
Reis, Cristiane (Faculdade de Farmácia UFMG, Belo Horizonte, Brazil)
Marinho, Juliana (Faculdade de Farmácia UFMG, Belo Horizonte, Brazil) - Abstract:
Fourth-generation fluoroquinolones are broad-spectrum antibiotics frequentely used to treat a wide variety of infections. Gatifloxacin is one of the newest and the most effective quinolones. This study intended to identify suspected adverse drug reactions (ADR) with gatifloxacin and establish their frequency; to describe the ADR identified and
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026